Cover Image

Exploring sequence specific silencing of latent HIV using CRISPR interference

Saved in:

Bibliographic Details
Main Authors:	R. Schwarzer (Author), M. Montano (Author), W.C. Greene (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disease-Causing Allele-Specific Silencing by RNA Interference
by: Hirohiko Hohjoh
Published: (2013)

CRISPR Interference-Mediated Silencing of the <i>mmpL3</i> Gene in <i>Mycobacterium smegmatis</i> and Its Impact on Antimicrobial Susceptibility
by: Yonita Yuliani, et al.
Published: (2024)

Detection of Burkholderia pseudomallei with CRISPR-Cas12a based on specific sequence tags
by: Jia-Xin Zhang, et al.
Published: (2023)

22 Development of DOUBLE NICKASE CRISPR aganist latently infected human immunodeficency virus (HIV)
by: O.A. Ishola, et al.
Published: (2016)

Mcam Silencing With RNA Interference Using Magnetofection has Antitumor Effect in Murine Melanoma
by: Lara Prosen, et al.
Published: (2014)

Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
by: Chantal M. Ferguson, et al.
Published: (2020)

CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5' long terminal repeats to permanently inactivate latent provirus
by: B. Wigdahl, et al.
Published: (2019)

O5 CRISPR/Cas9-derived activation systems as new tools for induction of latent human immunodeficiency virus (HIV)
by: JuliaK Bialek, et al.
Published: (2016)

Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing
by: Chantelle Ahlenstiel, et al.
Published: (2015)

Single cell analysis of in vivo HIV reservoir uncovers novel markers of latent cells
by: N. Roan, et al.
Published: (2019)

Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia-The Future Is Here
by: Melody Hermel, et al.
Published: (2023)

Lymphoid tissue and blood CD4 T cells respond differently to latency-reversing agents: are we testing the right cells?
by: A. Gramatica, et al.
Published: (2015)

PP 1.5 - 00040 Mapping of genetic interaction networks identifies a nucleosomal modification complex for silencing HIV
by: Z. Li, et al.
Published: (2022)

Exploring How Silence Communicates
by: Dat Bao
Published: (2020)

PP 4.22 - 00087 Reversal of exhaustion of HIV-1-specific CTLs by CRISPR-mediated disruption of PD-1 gene
by: C. Baez, et al.
Published: (2022)

Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir
by: C. Gaebler
Published: (2019)

Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir
by: J. Karn, et al.
Published: (2019)

Identification of a promising new class of latency reversing agents
by: A. Gramatica, et al.
Published: (2017)

Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference
by: Masaki Takahashi, et al.
Published: (2015)

RNA interference as a gene silencing therapy for mutant <it>MYOC </it>protein in primary open angle glaucoma
by: Sun Xinghuai, et al.
Published: (2009)

Degenerate sequence-based CRISPR diagnostic for Crimean-Congo hemorrhagic fever virus.
by: Hongzhao Li, et al.
Published: (2022)

CRISPR/Cas9 targeting HIV-1 regulatory genes inactivates latent proviral DNA and prevents new infection in T cell culture with inhibition of viral escape
by: Y. Ophinni, et al.
Published: (2019)

CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations
by: Siyu Chen, et al.
Published: (2020)

Silences and silence in 'creativity'
Published: (2012)

gRNA Sequence Heterology Tolerance Catalyzed by CRISPR/Cas in an In Vitro Homology-Directed Repair Reaction
by: Amanda M. Hewes, et al.
Published: (2020)

CRISPR-Cas13a Inhibits HIV-1 Infection
by: Lijuan Yin, et al.
Published: (2020)

In vitro Inactivation of Latent HSV by Targeted Mutagenesis Using an HSV-specific Homing Endonuclease
by: Martine Aubert, et al.
Published: (2014)

Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies
by: M. Nonnemacher, et al.
Published: (2015)

Using barcoded HIV-1 to understand inducibility of the latent HIV-1 reservoir
by: E. Larragoite, et al.
Published: (2017)

Latent profile analysis of blood marker phenotypes and their relationships with clinical pain and interference reports in people with acute musculoskeletal trauma
by: Joshua Y. Lee, et al.
Published: (2021)

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
by: Cheng-Han Chung, et al.
Published: (2020)

Rapid, sensitive, and highly specific detection of monkeypox virus by CRISPR-based diagnostic platform
by: Lin Gong, et al.
Published: (2023)

The Chromatin Structure Differentially Impacts High-Specificity CRISPR-Cas9 Nuclease Strategies
by: Xiaoyu Chen, et al.
Published: (2017)

Adventures in Silence
by: Collingwood, Herbert W. (Herbert Winslow), 1857-1927

8 IFNα activates latent HIV-1 in non-proliferating latently infected T-cells
by: R.M. Sluis, van der, et al.
Published: (2016)

Ingenol derivatives are potent reactivators of latent HIV
by: V. Planelles, et al.
Published: (2015)

Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing
by: Qianying Zhao, et al.
Published: (2018)

PP 1.28 - 00156 The HIV-1 antisense RNA Ast promotes viral latency via epigenetic silencing of the proviral 5'LTR and is expressed in latently infected cells from ART-suppressed donors
by: F. Romerio, et al.
Published: (2022)

Expression profiling of HIV latently-infected cells using nanostring and mass cytometry
by: H. Sperber, et al.
Published: (2019)

Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
by: Christian Dohmen, et al.
Published: (2012)